Skip to main navigation Skip to search Skip to main content
No photo of Moshe Gatt

View Scopus Profile

Moshe Gatt

Former affiliation
 https://orcid.org/0000-0002-9426-4482
1998 …2026

Research activity per year

Personal profile

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics where Moshe Gatt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further

  • Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab

    Kumar, S., Mateos, M. V., Ye, J. C., Atrash, S., Magen, H., Quach, H., Chu, M. P., Trudel, S., Richter, J., Rodríguez-Otero, P., Chuah, H., Gatt, M., Medvedova, E., Raza, S., Yoon, D. H., Ishida, T., Matous, J. V., Rosiñol, L., Onodera, K. & Scott, E. & 15 others, Heuck, C., Zhang, J., Henninger, T., O’Rourke, L., Thakkar, P., Festa, M., Huang, L., Zhou, J., Takamoto, M., Pei, L., Lu, J., Au, N., Krevvata, M., Usmani, S. Z. & Cohen, Y. C., 1 Jan 2026, In: New England Journal of Medicine. 394, 1, p. 51-61 11 p.

    Research output: Contribution to journal › Article › peer-review

    11 Scopus citations

  • Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis

    Shragai, T., Ganayem, M., Cohen, Y. C., Avivi, I., Lebel, E., Even-Gross Zohar, N., Melamed, N. & Gatt, M. E., Apr 2026, In: Annals of Hematology. 105, 4, 172.

    Research output: Contribution to journal › Article › peer-review

    Open Access

  • Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy

    Cohen, I., Lebel, E., Grisariu, S., Avni, B., Kfir-Erenfeld, S., Asherie, N., Zimran, E., Vainstein, V., Assayag, M., Sharon, T. D., Alexander-Shani, R., Bessig, N., Shehadeh, A., Ishtay, A., Schlossberg, M., Pick, M., Gatt, M. E., Bdolah-Abram, T., Stepensky, P. & Elias, S., Apr 2026, In: International Journal of Molecular Sciences. 27, 7, 3113.

    Research output: Contribution to journal › Article › peer-review

    Open Access

  • A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma

    Holstein, S. A., Atrash, S., Mian, H., Dimopoulos, M. A., Schjesvold, F., Popat, R., Shah, N., Gatt, M. E., Gocke, C. B., Frenzel, L., Touzeau, C., Beksac, M., Manier, S., Magen, H., Travis, P., Nadeem, O., Suryanarayan, K., Li, C., Li, S. & Nelson, A. & 3 others, Cherepanov, D., Parot, X. & Vogl, D. T., 28 Aug 2025, In: Blood. 146, 9, p. 1051-1064 14 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    2 Scopus citations

  • Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature

    Lebel, E., Vainstein, V., Milani, P., Palladini, G., Shragai, T., Lavi, N., Magen, H., Assayag, M., Avivi, I. & Gatt, M. E., 1 Jul 2025, In: Acta Haematologica. 148, 4, p. 419-426 8 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    4 Scopus citations
View all 124 Research outputs